Do you want to join?
Benefits
Sector representation and coordination: acts as a unified voice representing the interests of companies in the sector before government and regulatory authorities and other relevant stakeholders.
This strengthens companies' ability to participate in the drafting of public policies and regulations that affect the generics and biosimilars market.
Access to strategic information: as an entity that brings together the main players in the market, PróGenéricos provides access to strategic information, market trends, regulatory data and relevant updates, essential for the strategic planning and decision-making of member companies.
Networking and Collaboration: allows companies to establish and strengthen networks with other members of the sector, including manufacturers, distributors, consultants and specialists. This facilitates collaboration on joint initiatives, sharing best practices and exchanging experiences.
Defense of common interests: works to defend the common interests of member companies, including issues such as intellectual property, health regulation, policies on access to medicines, among other crucial issues for the development and sustainable growth of the generics and biosimilars market.
Global market trends: is an active member of the International Generic and Biosimilar Medicines Association (IGBA), with global representation and cooperation with bodies and initiatives such as the World Health Organization (WHO), the International Council for Harmonization (ICH) and the World Trade Organization (WTO), among others. By removing border barriers, our members have access to the same information discussed around the world in real time.
This strengthens companies' ability to participate in the drafting of public policies and regulations that affect the generics and biosimilars market.
Access to strategic information: as an entity that brings together the main players in the market, PróGenéricos provides access to strategic information, market trends, regulatory data and relevant updates, essential for the strategic planning and decision-making of member companies.
Networking and Collaboration: allows companies to establish and strengthen networks with other members of the sector, including manufacturers, distributors, consultants and specialists. This facilitates collaboration on joint initiatives, sharing best practices and exchanging experiences.
Defense of common interests: works to defend the common interests of member companies, including issues such as intellectual property, health regulation, policies on access to medicines, among other crucial issues for the development and sustainable growth of the generics and biosimilars market.
Global market trends: is an active member of the International Generic and Biosimilar Medicines Association (IGBA), with global representation and cooperation with bodies and initiatives such as the World Health Organization (WHO), the International Council for Harmonization (ICH) and the World Trade Organization (WTO), among others. By removing border barriers, our members have access to the same information discussed around the world in real time.
How does the
Adhesion Process work?
1°) The interested company formalizes its interest in joining, which is then submitted to the board.
2) After approval, the company becomes a member of the association.
3) The monthly fee is calculated on the basis of its market share, guaranteeing a contribution proportional to its size.
2) After approval, the company becomes a member of the association.
3) The monthly fee is calculated on the basis of its market share, guaranteeing a contribution proportional to its size.
Tell us about your venture:
WANT TO KNOW MORE
ABOUT
ABOUT US
Contact PróGenéricos
Questions or suggestions? Contact us by e-mail or telephone.